3[1]Bray GA,York DA.Clinical review 90:Leptin and clinical medicine:A new piece in the puzzle of obesity.J Clin Endocrinol Metab,1997,82:2771-2776.
4[2]Considine RV,Sinha MK,Heimam ML,et al.Serum immunoreactive-lepein concentrations in normal-weight and obese humans.N Engl J Med,1996,334:292-296.
5[3]Caro JF,Sinha IK,Kolaczynlki JW,et al.Leptin:the tale of an obesity gene.Diabetes,1996,45:1455-1462.
6[4]Bai Y,Zhang S,Kim KS,et al.Obese gene expression alters the ability of 30 A5 preadipocytes to respond to lipogenic hormones.J Biol Chem,1996,271:13939-13942.
7[5]Timothy JTJ,Kieffer RS,Holler CA,et al.Leptin suppression of in sulin secretion by the activation of ATP-sensitive k+ channels in pancreatic β-cells.Diabetes,1997,46:1087-1093.
8[6]Gong DW,He Y,Karas M,et al.Uncoupling protein-3 is a me-diator of thermogenesis by thyroed hormone,beta3adrenergic agwnists,and leptin.Biol Chem,1997,272:24129-24132.
9[7]Solanes G,Vidal-Puig A,Grujic D,et al.The human uncou-pling protein-3 gene:genomic structure,chromosomal localiza-tian,and genetic basis for short and long form transcripts.J Biol Chen,1997,272:25433-25436.
10[8]Krook A,Digbyi J,O'Rahilly S,et al.Uncoupling protein 3 is reduced in skeletal muscle of NIDDM pateents.Diabetes,1998,47:1528-1531.
